References
- Reed E. Should cost be considered in the overall evaluation of phase II clinical trials of new antineoplastic therapies? A response. Cancer Invest 1998; 16(2)135–139
- Pellegrino E D. Managed care and managed competition: Some ethical reflections. Calyx 1994; 4: 1–5
- Rosner F. The ethics of managed care. Mt Sinai J Med 1997; 64: 8–19